Amended and Restated Voting and Standstill Agreement


 Exhibit 10.2 
 EXECUTION COPY 
 AMENDED AND RESTATED VOTING AND STANDSTILL AGREEMENT

 THIS AMENDED AND RESTATED VOTING AND STANDSTILL AGREEMENT (this “Agreement”) is made and entered
into as of February 1, 2011 by and among iGate Corporation, a Pennsylvania corporation, for purposes of Article V only, (the “Company”), Viscaria Limited, a private company limited by shares formed under the Laws of
Cyprus (the “Investor”) and each of Mr. Sunil Wadhwani, Wadhwani Partners No. 1 LP, Wadhwani Partners No. 2 LP, Sunil and Nita Wadhwani Family Foundation, Mr. Ashok Trivedi and The Trivedi Family Qualified
Subchapter S Trust (collectively, the “Shareholders”, and each a “Shareholder”), and hereby amends and replaces in its entirety that certain Voting and Standstill Agreement, dated as of January 10, 2011, by and
among the Company, the Investor and the Shareholders. 
 WHEREAS, the Investor is party to that certain Securities Purchase
Agreement, dated as of the date hereof, by and among the Company and the Investor (the “Purchase Agreement”). Capitalized terms used herein and not otherwise defined shall have the respective meanings ascribed to such terms in
the Purchase Agreement; and 
 WHEREAS, the Investor and the Shareholders wish to agree among themselves as to the taking of
certain actions with respect to the Shareholder Approval; and 
 WHEREAS, the Investor and the Shareholders also wish to agree
among themselves as to the taking of actions with respect to the election of certain directors to the Board; and 
 WHEREAS, the
Investor and the Shareholders also wish to agree among themselves as to the taking of actions with respect to any additional approvals of the Shareholders required to fully effectuate the Investor’s rights under Section 3.1 (Right
of First Offer) and Section 3.3 (Preemptive Rights) of the Investor Rights Agreement and Section 4(b) (Participating Dividends) of the Series B Statement with Respect to Shares; and 

WHEREAS, as a condition of the willingness of the Investor to enter into the Purchase Agreement, and as an inducement and in
consideration therefor, each Shareholder has entered into this Agreement, and 
 WHEREAS, each Shareholder owns the number of
shares of common stock, par value $0.01 per share, of the Company as set forth on Schedule A hereto (the “Common Stock”), together with any other shares of capital stock of the Company acquired (whether beneficially or of
record) by any Shareholder after the date hereof and prior to the Expiration Time (as defined in Section 1.1 hereto), including any such shares acquired by means of purchase, dividend or distribution, or issued upon the exercise of any
options or warrants or the conversion of any convertible securities or otherwise, being collectively referred to herein as the “Securities”. 
 NOW, THEREFORE, in consideration of the foregoing, the mutual covenants and agreements set forth herein, and other good and valuable consideration, the receipt and sufficiency of which is hereby
acknowledged, the parties hereto agree as follows: 






 ARTICLE I 
 VOTING; GRANT AND APPOINTMENT OF PROXIES 
 Section 1.1 Voting by the
Shareholders. From and after the date hereof until the termination of this Agreement in accordance with Article VI (the “Expiration Time”), each Shareholder irrevocably and unconditionally hereby agrees that at any
meeting (whether annual or special and each adjourned or postponed meeting) of the Company’s shareholders, however called, or in connection with any written consent of the Company’s shareholders, each Shareholder will (i) appear at
such meeting or otherwise cause its Covered Securities (as defined below) to be counted as present thereat for purposes of calculating a quorum and (ii) vote or cause to be voted (including by proxy or written consent, if applicable) all of
such Shareholder’s voting securities beneficially owned or controlled by such Shareholder as of the relevant time (the “Covered Securities”), 
  

	 	(a)	in favor of the Shareholder Approval; 

  

	 	(b)	for so long as Investor and its Affiliates hold, in the aggregate, at least one third of the Conversion Stock issuable as of the Second Closing Date (or the First
Closing, if the Second Closing has not yet occurred) (whether or not such Conversion Stock has been issued or is held through Preferred Stock or as a combination thereof), in favor of the election to the Board of (i) one director (if the total
number of directors of the Company is nine or less), and two directors (if the total number of directors of the Company is ten or more), in each case, nominated by the Investor and (ii) any Series B Directors (as defined in the Series B
Statement with Respect to Shares) in accordance with Section 11(b)(ii) of the Series B Statement with Respect to Shares; 

  

	 	(c)	in favor of any additional approvals of the shareholders of the Company required under any regulation or rule of any Trading Market (as defined in the Series B
Statement with Respect to Shares) on which the Company’s stock is listed, in order to fully effectuate the Investor’s rights under Section 3.1 (Right of First Offer) and Section 3.3 (Preemptive Rights) of the Investor Rights
Agreement and Section 4(b) (Participating Dividends) of the Series B Statement with Respect to Shares; and 

  

	 	(d)	against any other action, agreement or transaction, that is intended, that could reasonably be expected, or the effect of which could reasonably be expected, to
materially impede, interfere with, delay, postpone, discourage or adversely affect the approvals and actions in Sections 1.1(a), (b) or (c) hereto. 


Section 1.2 Voting by the Investor. Subject to the occurrence of the First Closing, from and after the effectiveness of the
First Closing until the Expiration Time, the Investor irrevocably and unconditionally hereby agrees that at any meeting (whether annual or special and each adjourned or postponed meeting) of the Company’s shareholders, however called, or in
connection with any written consent of the Company’s shareholders, the Investor will (i) appear 

  
 2 







 
at such meeting or otherwise cause its Investor Securities (as defined below) to be counted as present thereat for purposes of calculating a quorum and (ii) vote or cause to be voted
(including by written consent, if applicable) all of the Investor’s voting Preferred Stock and Conversion Stock (collectively, the “Investor Securities”) beneficially owned or controlled by the Investor as of the relevant time,

  

	 	(a)	for so long as Sunil Wadhwani and his Affiliates beneficially own, in the aggregate, not less than three percent (3%) of the total outstanding Common Stock, in
favor of the election of Sunil Wadhwani (or his nominee) to the Board; 

  

	 	(b)	for so long as Ashok Trivedi and his Affiliates beneficially own, in the aggregate, not less than three percent (3%) of the total outstanding Common Stock, in
favor of the election of Ashok Trivedi (or his nominee) to the Board; and 

  

	 	(c)	against any other action, agreement or transaction, that is intended, that could reasonably be expected, or the effect of which could reasonably be expected, to
materially impede, interfere with, delay, postpone, discourage or adversely affect the election of such Shareholder (or respective nominee) to the Board. 

 Notwithstanding anything to the contrary in this Agreement or any other Transaction Document, the Investor, the Company and each of the Shareholders acknowledge and agree that this Section 1.2
shall temporarily be of no force or effect immediately upon the occurrence and continuation of an (i) Event of Noncompliance (as defined in the Series B Statement with Respect to Shares) or (ii) Event of Default (as defined in the Investor
Rights Agreement), in each case, through the time such Event of Noncompliance or Event of Default, as applicable, shall have been cured. 
 ARTICLE II 
 GRANT OF IRREVOCABLE PROXIES; APPOINTMENT OF PROXIES 

Section 2.1 Grant of Irrevocable Proxies. From and after the date hereof until the Shareholder Approval is obtained, each
Shareholder hereby irrevocably and unconditionally grants to, and appoints, the Company and any designee thereof as such Shareholder’s proxy and attorney-in-fact (with full power of substitution), for and in the name, place and stead of such
Shareholder, to vote or cause to be voted (including by proxy or written consent, if applicable) the Covered Securities in accordance with Section 1.1(a) hereto. 
 Section 2.2 Affirmation of Irrevocable Proxy. Each Shareholder hereby affirms that the irrevocable proxy set forth in this Article II is given in connection with the execution of the
Purchase Agreement, and that such irrevocable proxy is given to secure the performance of the duties of each Shareholder under this Agreement. Each Shareholder hereby further affirms that the irrevocable proxy is coupled with an interest and, except
as set forth in this Article II, is intended to be irrevocable. If for any reason a proxy granted herein is not irrevocable, then each Shareholder agrees to vote the Covered Securities in accordance with Section 2.1 above as


  
 3 







 
instructed by the Company in writing. The parties agree that the foregoing is a voting agreement. 
 Section 2.3 Restrictions on Transfers. Each Shareholder hereby agrees that from the date hereof until the Shareholder Approval is obtained, he, she or it shall not, directly or indirectly,
(a) sell, transfer, assign, tender in any tender or exchange offer, pledge, encumber, hypothecate or similarly dispose of (by merger, by testamentary disposition, by operation of Law or otherwise), either voluntarily or involuntarily, or to
enter into any Contract, option or other arrangement or understanding with respect to the sale, transfer, assignment, pledge, lien, hypothecation or similar disposition of (by merger, by testamentary disposition, by operation of Law or otherwise),
any Covered Securities, (b) deposit any Securities into a voting trust or enter into a voting agreement or arrangement or grant any proxy, consent or power of attorney with respect thereto that is inconsistent with this Agreement, or
(c) agree (whether or not in writing) to take any of the actions referred to in the foregoing clause (a) or (b); provided, that the restrictions set forth in this Section 2.3 shall not apply to any
transfers by any Shareholder to any Person in connection with estate planning so long as such Person agrees to be bound by the terms of this Agreement. 
 Section 2.4 Inconsistent Agreements. Each Shareholder hereby covenants and agrees that, except for this Agreement, each Shareholder (a) has not entered into any voting agreement or
arrangement or voting trust with respect to the Covered Securities and (b) has not granted a proxy, consent or power of attorney with respect to the Covered Securities. Each Shareholder hereby represents that any proxies heretofore given in
respect of such Shareholder’s Covered Securities, if any, are revocable, and hereby revokes such proxies. 
 ARTICLE III

 REPRESENTATIONS, WARRANTIES AND COVENANTS 
 OF EACH SHAREHOLDER 
 Section 3.1 Representations and Warranties. Each
Shareholder represents and warrants to the Investor as follows: (a) such Shareholder, if an individual, has full legal right and capacity to execute and deliver this Agreement, to perform the Shareholder’s obligations hereunder and to
consummate the transactions contemplated hereby, (b) this Agreement has been duly executed and delivered by such Shareholder and the execution, delivery and performance of this Agreement by such Shareholder and the actions contemplated hereby
have been duly authorized by all necessary action on the part of such Shareholder and no other actions or proceedings on the part of such Shareholder are necessary to authorize this Agreement or the actions contemplated hereby, (c) assuming
this Agreement constitutes the valid and binding agreement of each of the other Shareholders and the Investor, this Agreement constitutes the valid and binding agreement of such Shareholder, enforceable against such Shareholder in accordance with
its terms, (d) the execution and delivery of this Agreement by such Shareholder does not, and the consummation of the transactions contemplated hereby and the compliance with the provisions hereof will not, conflict with or violate any Law or
agreement binding upon such Shareholder or such Shareholder’s Covered Securities, nor require any authorization, consent or approval of, or filing with, any governmental entity, except for filings with the United States Securities and Exchange
Commission by such Shareholder, and (e) except for such transfer restrictions of general applicability as may be provided under the Securities Act of 1933, 

  
 4 







 
as amended, and the “blue sky” Laws of the various states of the United States, such Shareholder owns, beneficially and of record, or controls all of his, her or its Covered Securities
(and will own, beneficially and on record, or control any additional Covered Securities acquired after the date hereof) free and clear of any proxy, voting restriction, adverse claim or other lien (other than any restrictions created by this
Agreement) and has sole voting power with respect to such Covered Securities and sole power of disposition with respect to all of such Shareholder’s Covered Securities, with no restrictions on the Shareholder’s rights of voting or
disposition pertaining thereto and no person other than such Shareholder has any right to direct or approve the voting or disposition of any of the Shareholder’s Securities. 

Section 3.2 Covenants. Each Shareholder hereby: 
 (a) agrees, prior to the Expiration Time, not to take any action that would make any representation or warranty of such Shareholder contained herein untrue or incorrect or have or would reasonably be
expected to have the effect of preventing, impeding or interfering with or adversely affecting the performance by each Shareholder of its obligations under this Agreement; 
 (b) agrees that the Company may permit the Investor to publish, if required under applicable Law, such Shareholder’s identity and ownership of Common Stock and the nature of such Shareholder’s
commitments, arrangements and understandings under this Agreement in any proxy statement used in connection with soliciting the Shareholder Approval; 
 (c) shall and does authorize the Company or its counsel to, notify the Company’s transfer agent that there is a stop transfer order with respect to all of the Covered Securities (and that this
Agreement places limits on the voting and transfer of such shares); and 
 (d) agrees that, upon request of the Investor, each
Shareholder shall execute and deliver any additional documents and take such further actions as may reasonably be deemed by the Investor to be necessary or desirable to carry out the provisions of this Agreement. 

ARTICLE IV 

REPRESENTATIONS AND WARRANTIES OF THE INVESTOR 
 Section 4.1 Representations and Warranties of the Investor. The Investor hereby represents and warrants to each of the Shareholders and the Company as follows: (a) this Agreement has been
duly and validly authorized by the Investor, (b) this Agreement has been duly executed and delivered by the Investor, (c) assuming this Agreement constitutes a valid and binding agreement of each Shareholder and the Company, as applicable,
this Agreement constitutes a valid and binding agreement of the Investor, enforceable against the Investor in accordance with its terms and (d) the execution and delivery of this Agreement by the Investor does not, and the consummation of the
transactions contemplated hereby and the compliance with the provisions hereof will not, conflict with or violate any Law or agreement or organizational documents binding upon the Investor, nor require any authorization, consent or


  
 5 







 
approval of, or filing with, any governmental entity except for filings with the United States Securities and Exchange Commission by such Shareholder. 

ARTICLE V 

REPRESENTATIONS, WARRANTIES AND COVENANTS OF THE COMPANY 
 Section 5.1 Representations and Warranties of the Company. The Company hereby represents and warrants to each of the Shareholders and to the Investor as follows: (a) this Agreement has
been duly and validly authorized by the Company, (b) this Agreement has been duly executed and delivered by the Company, (c) assuming this Agreement constitutes a valid and binding agreement of each Shareholder and the Investor, as
applicable, this Agreement constitutes a valid and binding agreement of the Company, as applicable, enforceable against the Company, as applicable, in accordance with its terms and (d) the execution and delivery of this Agreement by the Company
does not, and the consummation of the transactions contemplated hereby and the compliance with the provisions hereof will not, conflict with or violate any Law or agreement or organizational documents binding upon the Company, nor require any
authorization, consent or approval of, or filing with, any governmental entity except for filings with the United States Securities and Exchange Commission by the Company. 
 Section 5.2 Covenants. The Company hereby agrees to vote or cause to be voted the Covered Securities only in accordance with this Agreement. 

ARTICLE VI 

TERMINATION 

Section 6.1 This Agreement shall automatically terminate and be of no further force or effect upon the date on which both the
Shareholder Approval has been obtained and the Shareholders are no longer required to vote to elect each Series B Director pursuant to Section 1.1(b) of this Agreement; provided that this Agreement shall automatically terminate
upon the termination of the Purchase Agreement in accordance with its terms prior to the First Closing. Notwithstanding the preceding sentence, Article VII shall survive any termination of this Agreement. Nothing in this Article VI
shall relieve or otherwise limit any party of liability for willful breach of this Agreement. 
 ARTICLE VII 

MISCELLANEOUS 

Section 7.1 Expenses. Except as otherwise may be agreed in writing, all costs, fees and expenses incurred in connection with
this Agreement and the transactions contemplated hereby shall be paid by the party incurring or required to incur such costs, fees and expenses. 
 Section 7.2 Notices. Unless otherwise provided, any notice required or permitted under this Agreement shall be given in writing and shall be deemed effectively given as hereinafter described
(a) if given by personal delivery, then such notice shall be deemed given upon such delivery, (b) if given by facsimile or electronic transmission, then such notice shall be deemed given upon receipt of confirmation of complete
transmittal, (c) if given by mail, then such notice shall be deemed given upon the earlier of (i) receipt of such notice by the recipient or (ii) three days after such notice is deposited in first class mail, postage prepaid, and
(d) if given 

  
 6 







 
by an internationally recognized overnight air courier, then such notice shall be deemed given one Business Day after delivery to such carrier. All notices shall be addressed to the party to be
notified at the address as follows, or at such other address as such party may designate by written notice to the other party: 

To the Company: 
 iGate Corporation 
 6528 Kaiser Drive, 

Fremont, CA 94555 
 Attention: Phaneesh Murthy 
 Fax: (510) 896-3010 

with a copy to (which shall not constitute notice): 
 Latham & Watkins LLP 
 355 South Grand Avenue 

Los Angeles, CA 90071-1560 
 Attention: Cynthia A. Rotell 
 Fax: (213) 891-8763 

To the Investor: 
 Viscaria Limited 
 c/o Aspen Secretarial Services 

Lemesou, 77 

Elia House 

P.C. 2121, Nicosia, Cyprus 
 Attention: Secretary of the Company 
 Fax: + 357 2241 8801 

with copies to (solely in its capacity as investment advisor or investment manager as the case may be), which shall not constitute notice
to Investor: 
 Apax Partners Europe Managers Limited 
 33 Jermyn Street 
 London SW1Y 6DN 

United Kingdom 

Attention: Salim Nathoo 
 Fax: +44 20 7666 6441 
 and 

  
 7 







 Apax Partners India Advisers Private Limited 

2nd Floor, Devchand House 
 Shivsagar Estate 
 Dr Annie Besant Road 

Worli, Mumbai 400 018, India 
 Attention:  Shashank Singh 

                  Rohan Haldea 

Fax: +91 22 4050 8444 
 with a copy to (which shall not constitute notice to Investor): 

Kirkland & Ellis LLP 
 601 Lexington Avenue 
 New York, New York 10022 

Attention:  Frederick Tanne 
                   Susan J. Zachman 
 Fax: 212-446-6460 
 To the Shareholders: 

1000 Commerce Drive, 
 Suite 500 
 Pittsburgh, PA 15275 

Attention: Sunil Wadhwani 
 Fax: 412-291-1188 
 and 

1000 Commerce Drive, 
 Suite 500 
 Pittsburgh, PA 15275 

Attention: Ashok Trivedi 
 Fax: 412-291-1154 
 with a copy to (which shall not constitute notice):

 Reed Smith LLP 
 225 Fifth Avenue 
 Pittsburgh, PA 15222-2716 

Attention: James J. Barnes 
 Fax: (412) 288-3063 
 Section 7.3 Amendments; Waivers. At any
time prior to the Expiration Time, any provision of this Agreement may be amended or waived if, and only if, such amendment or waiver is in writing and signed, in the case of an amendment, by the Company, each of the Shareholders and the Investor,
or in the case of a waiver, by the party against whom the waiver is to be effective. Notwithstanding the foregoing, no failure or delay by the Company, the 

  
 8 







 
Shareholders or the Investor in exercising any right hereunder shall operate as a waiver thereof nor shall any single or partial exercise thereof preclude any other or further exercise of any
other right hereunder. 
 Section 7.4 Assignment; Binding Effect. Neither this Agreement nor any of the rights,
interests or obligations hereunder shall be assigned by any of the parties hereto (whether by operation of Law or otherwise) without the prior written consent of the other parties, except that each Investor may assign, in its sole discretion, any of
or all of its rights, interest and obligations under this Agreement to any Affiliate of an Investor, but no such assignment shall relieve such Investor of its obligations hereunder. Subject to the preceding sentence, this Agreement shall be binding
upon and shall inure to the benefit of the parties hereto and their respective permitted successors and assigns. Each Investor shall cause any assignee thereof to perform its obligations under this Agreement and shall be responsible for any failure
of such assignee to comply with any representation, warranty, covenant or other provision of this Agreement. 
 Section 7.5
No Partnership, Agency, or Joint Venture. This Agreement is intended to create, and creates, a contractual relationship and is not intended to create, and does not create, any agency, partnership, joint venture or any like relationship
between the parties hereto. 
 Section 7.6 Entire Agreement; Benefit. This Agreement is intended by the parties as a
final expression of their agreement and intended to be a complete and exclusive statement of the agreement and understanding of the parties hereto in respect of the subject matter contained herein. This Agreement and the other Transaction Documents
supersede all prior agreements and understandings between the parties with respect to such subject matter. 
 Section 7.7
Severability. If any provision of this Agreement or the application of any such provision to any Person or circumstance shall be declared by any court of competent jurisdiction to be invalid, illegal, void or unenforceable in any respect, all
other provisions of this Agreement, or the application of such provision to Persons or circumstances other than those as to which it has been held invalid, illegal, void or unenforceable, shall nevertheless remain in full force and effect and will
in no way be affected, impaired or invalidated thereby. Upon such determination that any provision, or the application of any such provision, is invalid, illegal, void or unenforceable, the parties hereto shall negotiate in good faith to modify this
Agreement so as to effect the original intent of the parties hereto as closely as possible to the fullest extent permitted by Law in an acceptable manner to the end that the transactions contemplated hereby are fulfilled to the greatest extent
possible. 
 Section 7.8 Governing Law. This Agreement, and all claims or causes of action (whether at Law, in
contract or in tort) that may be based upon, arise out of or relate to this Agreement, or the negotiation, execution or performance hereof, shall be governed by and construed in accordance with the Laws of the State of Pennsylvania, without giving
effect to any choice or conflict of law provision or rule (whether of the State of Pennsylvania or any other jurisdiction) that would cause the application of the Laws of any jurisdiction other than the State of Pennsylvania. 

Section 7.9 Jurisdiction; Enforcement. Each of the parties hereto irrevocably submits to the exclusive jurisdiction of the
courts of the State of New York located in New York County 

  
 9 







 
and the United States District Court for the Southern District of New York for the purpose of any suit, action, proceeding or judgment relating to or arising out of this Agreement and the
transactions contemplated hereby. Service of process in connection with any such suit, action or proceeding may be served on each party hereto anywhere in the world by the same methods as are specified for the giving of notices under this Agreement.
Each of the parties hereto irrevocably consents to the jurisdiction of any such court in any such suit, action or proceeding and to the laying of venue in such court. Each party hereto irrevocably waives any objection to the laying of venue of any
such suit, action or proceeding brought in such courts and irrevocably waives any claim that any such suit, action or proceeding brought in any such court has been brought in an inconvenient forum. EACH OF THE PARTIES HERETO WAIVES ANY RIGHT TO
REQUEST A TRIAL BY JURY IN ANY LITIGATION WITH RESPECT TO THIS AGREEMENT AND REPRESENTS THAT COUNSEL HAS BEEN CONSULTED SPECIFICALLY AS TO THIS WAIVER. 
 Section 7.10 Remedies. The Company and each of the Shareholders acknowledges that monetary damages would not be an adequate remedy in the event that any covenant or agreement in this Agreement
is not performed in accordance with its terms, and it is therefore agreed that, in addition to and without limiting any other remedy or right it may have, the Investor will have the right to an injunction, temporary restraining order or other
equitable relief in any court of competent jurisdiction enjoining any such breach and enforcing specifically the terms and provisions hereof. The Company and each of the Shareholders agrees not to oppose the granting of such relief in the event a
court determines that such a breach has occurred, and to waive any requirement for the securing or posting of any bond in connection with such remedy. All rights, powers, and remedies provided under this Agreement or otherwise available in respect
hereof at Law or in equity shall be cumulative and not alternative, and the exercise or beginning of the exercise of any thereof by the Investor shall not preclude the simultaneous or later exercise of any other such right, power or remedy by such
party. 
 Section 7.11 Titles and Subtitles; Rules of Construction. The titles and subtitles used in this Agreement
are used for convenience only and are not to be considered in construing or interpreting this Agreement. All references to “Section” or “Sections” refer to the corresponding Section or Sections of this Agreement. Defined terms
used in this Agreement in the singular shall include the plural and vice versa. Whenever the words “include,” “includes” or “including” are used in this Agreement, they are deemed to be followed by the words
“without limitation.” Any definitions used herein defined in the plural shall be deemed to include the singular as the context may require and any definitions used herein defined in the singular shall be deemed to include the plural as the
context may require. Wherever reference is made herein to the male, female or neuter genders, such reference shall be deemed to include any of the other genders as the context may require. 

Section 7.12 No Strict Construction. The language used in this Agreement shall be deemed to be the language chosen by the
parties hereto to express their mutual intent, and no rule of strict construction shall be applied against any Person. 

Section 7.13 Counterparts; Facsimiles and Electronic Copies. This Agreement may be executed in two or more counterparts, each
of which shall be deemed an original, but all of which together shall constitute one and the same instrument. This Agreement may also be 

  
 10 








 
executed via facsimile or other electronic copy (including copies sent via email), which shall be deemed an original. 
 [Signature Pages to Follow] 

  
 11 








 IN WITNESS WHEREOF, the parties hereto have duly executed and delivered this Agreement as of
the date and year first written above. 
  

									
		 		 	COMPANY:
			
	FOR PURPOSES OF ARTICLE V ONLY:	 		 	iGATE CORPORATION
				
		 		 	By:	 	 /s/ Sujit Sircar

		 		 		 	Name:	 	Sujit Sircar
		 		 		 	Title:	 	Chief Financial Officer

 [Signature Page to
Amended and Restated Voting and Standstill Agreement] 






 IN WITNESS WHEREOF, the parties hereto have duly executed and delivered this Agreement as of
the date and year first written above. 
  

					
	VISCARIA LIMITED
		
	By:	 	 /s/ Andreas Athinodorou

		 	Name:	 	Andreas Athinodorou
		 	Title:	 	Director


 [Signature Page to Amended
and Restated Voting and Standstill Agreement] 






 IN WITNESS WHEREOF, the parties hereto have duly executed and delivered this Agreement as of
the date and year first written above. 
  

	
	SHAREHOLDER:
	
	 /s/ Sunil Wadhwani

	SUNIL WADHWANI


 [Signature Page
to Amended and Restated Voting and Standstill Agreement] 






 IN WITNESS WHEREOF, the parties hereto have duly executed and delivered this Agreement as of
the date and year first written above. 
  

					
	SHAREHOLDER:
	
	WADHWANI PARTNERS NO. 1 LP
		
	By:	 	 /s/ Sunil Wadhwani

		 	Name:	 	Sunil Wadhwani
		 	Title:	 	Majority in Interest of the General Partners


 [Signature Page to Amended and Restated Voting and Standstill Agreement] 






 IN WITNESS WHEREOF, the parties hereto have duly executed and delivered this Agreement as of
the date and year first written above. 
  

					
	SHAREHOLDER:
	
	WADHWANI PARTNERS NO. 2 LP
		
	By:	 	 /s/ Sunil Wadhwani

		 	Name:	 	Sunil Wadhwani
		 	Title:	 	Majority in Interest of the General Partners


 [Signature Page to Amended and Restated Voting and Standstill Agreement] 






 IN WITNESS WHEREOF, the parties hereto have duly executed and delivered this Agreement as of
the date and year first written above. 
  

					
	SHAREHOLDER:
	
	SUNIL AND NITA WADHWANI FAMILY FOUNDATION
		
	By:	 	 /s/ Sunil Wadhwani

		 	Name:	 	Sunil Wadhwani
		 	Title:	 	Director, President and Treasurer



[Signature Page to Amended and Restated Voting and Standstill Agreement] 






 IN WITNESS WHEREOF, the parties hereto have duly executed and delivered this Agreement as of
the date and year first written above. 
  

	
	SHAREHOLDER:
	
	 /a/ Ashok K. Trivedi

	ASHOK K. TRIVEDI


 [Signature Page
to Amended and Restated Voting and Standstill Agreement] 






 IN WITNESS WHEREOF, the parties hereto have duly executed and delivered this Agreement as of
the date and year first written above. 
  

					
	SHAREHOLDER:
	
	THE TRIVEDI FAMILY QUALIFIED SUBCHAPTER S TRUST
		
	By:	 	 /s/ Ashok K. Trivedi

		 	Name:	 	Ashok K. Trivedi
		 	Title:	 	Co-Trustee


 [Signature Page to
Amended and Restated Voting and Standstill Agreement] 






 Schedule A 

 

					
	 Shareholder
	  	Shares of Common Stock	 
		
	 Sunil Wadhwani
	  	 	10,106,551	  
		
	 Wadhwani Partners No. 1 LP
	  	 	60,124	  
		
	 Wadhwani Partners No. 2 LP
	  	 	1,820,000	  
		
	 Sunil and Nita Wadhwani Family Foundation
	  	 	515,000	  
		
	 Ashok K. Trivedi
	  	 	10,714,082	  
		
	 The Trivedi Family Qualified Subchapter S Trust
	  	 	1,787,593